M.D. Lamiya Aliyeva Javit is a specialist in Medical Genetics, bringing a vital expertise in diagnosing and managing genetic conditions. She graduated from Uludag University Faculty of Medicine, where she honed her skills in this complex and evolving field. Since 2021, she has been an integral part of the Acibadem Health Group team, applying her knowledge to provide precise and compassionate patient care.
Her practice is built on a strong foundation of genetic medicine combined with a hands-on, patient-centered approach. M.D. Aliyeva Javit is dedicated to staying at the forefront of advances in genetics, ensuring her patients benefit from the latest diagnostic and counseling techniques. She is committed to clear communication, helping individuals and families understand their genetic health and make informed decisions about their care.
Experience
With a career spanning + years, M.D. Lamiya Aliyeva Javit has served in various esteemed medical centers, contributing to both outpatient and surgical care across a wide spectrum of cases.
Acibadem Health Group( 2021-01-01 Current)
Uludağ University Faculty of Medicine(Department of Medical Genetics / Assoc. Assist. Dr. 2016-01-01 - 2020-01-01)
On behalf of Kübra Ferecova Elmi Tedqiqat Pediatriya Institute(Baku / Assistant Doctor 2011-01-01 - 2014-01-01)
Frequently Asked Questions
Explore answers to commonly asked questions related to treatments, consultations, and services provided by M.D. Lamiya Aliyeva Javit.
M.D. Lamiya Aliyeva Javit, a renowned Genetic Medicine in Istanbul, practices at Acibadem Atakent Hospital, Istanbul. You can consult the doctor for expert and personalized care.
Booking an appointment with M.D. Lamiya Aliyeva Javit is simple. Visit MediFyr, go to the doctor’s profile, and schedule a clinic visit or online video consultation instantly.
M.D. Lamiya Aliyeva Javit has received positive feedback from 4+ patients and is highly recommended by those users for quality healthcare and professionalism.
Yes, M.D. Lamiya Aliyeva Javit offers teleconsultation for patients who prefer virtual appointments. You can book an online session directly through Medifyr for safe and convenient care from home.
Patient Experience
Patients share their experiences and feedback about their treatment with M.D. Lamiya Aliyeva Javit, reflecting the doctor’s commitment to quality care, advanced treatment, and patient-focused service. Explore real stories from individuals who have trusted M.D. Lamiya Aliyeva Javit with their health.
A 28-year-old nomadic herder from rural Azerbaijan presented with unexplained muscle weakness and photosensitivity. Dr. Aliyeva Javit's genetic panel revealed a novel mutation in the FECH gene, causing a severe form of erythropoietic protoporphyria previously undocumented in the region. Treatment involved a tailored regimen of beta-carotene and lifestyle modifications, with the patient's family receiving genetic counseling about the autosomal recessive inheritance pattern.
A 45-year-old successful tech entrepreneur from Baku sought consultation for recurrent miscarriages with multiple partners. Whole-exome sequencing identified a balanced chromosomal translocation (46,XY,t(11;22)(q23;q11)) previously undetected. Dr. Aliyeva Javit coordinated with reproductive specialists to recommend preimplantation genetic diagnosis, resulting in the patient's first successful pregnancy after three attempts.
A 7-year-old refugee child from a conflict zone presented with developmental delay and unusual facial features. Chromosomal microarray analysis revealed a rare 16p11.2 microduplication syndrome. Dr. Aliyeva Javit organized a multidisciplinary team including speech therapists and educational specialists, while navigating complex ethical considerations regarding genetic testing in displaced populations.
A 62-year-old retired fisherman from the Caspian coast had a family history of early-onset dementia. Genetic testing confirmed hereditary cerebral amyloid angiopathy due to a pathogenic variant in the APP gene. Dr. Aliyeva Javit implemented a surveillance protocol for cerebral microbleeds and facilitated predictive testing for three adult children, each making different disclosure decisions.